|
|
|
Volumn 53, Issue SUPPL. 2, 2005, Pages 16-23
|
|
Pharmacokinetics of voriconazole
|
|
Author keywords
CYP2C19; Genetic polymorphism; Loading dose; Pharmacokinetics; Voriconazole
|
|
Indexed keywords
ASTEMIZOLE;
BETA CYCLODEXTRIN SULFOBUTYL ETHER;
CARBAMAZEPINE;
CIMETIDINE;
CISAPRIDE;
CYCLOSPORIN;
CYTOCHROME P450 2C19;
CYTOCHROME P450 2C9;
CYTOCHROME P450 3A4;
DIGOXIN;
DRUG METABOLITE;
EFAVIRENZ;
ERGOT ALKALOID;
FLUCONAZOLE;
INDINAVIR;
MACROLIDE;
MICROSOME ENZYME;
MYCOPHENOLIC ACID;
OMEPRAZOLE;
PIMOZIDE;
PREDNISOLONE;
QUINIDINE;
RANITIDINE;
RAPAMYCIN;
TACROLIMUS;
TERFENADINE;
UNINDEXED DRUG;
VINCA ALKALOID;
VORICONAZOLE;
WARFARIN;
ARTICLE;
CANDIDA GLABRATA;
CANDIDA KRUSEI;
CEREBROSPINAL FLUID LEVEL;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG DOSE REGIMEN;
DRUG EXCRETION;
DRUG EXPOSURE;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG STRUCTURE;
DRUG TISSUE LEVEL;
ENZYME ACTIVITY;
ENZYME POLYMORPHISM;
FAT INTAKE;
FOOD DRUG INTERACTION;
GENOTYPE;
HUMAN;
KIDNEY FAILURE;
MAINTENANCE THERAPY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
TABLET FORMULATION;
URINARY EXCRETION;
|
|
EID: 29644443880
PISSN: 13407007
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (7)
|
